Mikamo lecture - A radical view of the 'superfamily' of cardiovascular risk factors

Circulation Journal

Volumn 67, Issue 10, 2003, Pages 805-809

  Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Atherosclerosis; Endothelium; Risk factors; Superoxide; Thrombomodulin

Indexed keywords

ACTIVATED PROTEIN C; OXYGEN RADICAL; SUPEROXIDE; THROMBIN; THROMBOMODULIN;

ANTICOAGULATION; ATHEROSCLEROSIS; BLOOD VESSEL; CARDIOVASCULAR RISK; CONFERENCE PAPER; REMISSION; TARGET ORGAN; THROMBOSIS; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

ARTERIOSCLEROSIS; BLOOD COAGULATION FACTOR INHIBITORS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FREE RADICALS; HUMANS; RISK FACTORS; SUPEROXIDES;

EID: 0141926595     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.805     Document Type: Conference Paper

References (38)

1. Henry PD, Yokoyama M. Supersensitivity of atherosclerotic rabbit aorta to ergonovine: Mediation by a serotonergic mechanism. J Clin Invest 1980; 66: 306-313.
2. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 1984; 54: 711-718.
3. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 1986; 58: 783-789.
4. Kauser K, da Cunha V, Fitch R, Mallari C, Rubanyi GM. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol Heart 2000; 278: H1679-H1685.
5. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice, Circulation 2001; 104: 448-454.
6. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
7. Napoli C, Paternò R, Faraci FM, Taguchi H, Postiglione A, Heistad DD. Oxidized low-density lipoprotein impairs responses of carotid but not basilar artery. Stroke 1997; 28: 2266-2272.
8. Didion SP, Hathaway CA, Faraci FM. Superoxide levels and function of cerebral blood vessels following inhibition of CuZnSOD. Am J Physiol 2001; 281: H1697-H1703.
9. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
10. Miller FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82: 1298-1305.
11. Jialal I, Devaraj S. Antioxidants and atherosclerosis: Don't throw out the baby with the bath water (Editorial). Circulation 2003; 107: 926-928.
12. Suzuki H, Swei A, Zweifach BW, Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension 1995; 25: 1083-1089.
13. Lund DD, Faraci FM, Miller FJ Jr, Heistad DD. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 2000; 101: 1027-1033.
14. Nakane H, Miller FJ Jr, Faraci FM, Toyoda K, Heistad DD. Gene transfer of eNOS reduces angiotensin II-induced endothelial dysfunction. Hypertension 2000; 35: 595-601.
15. Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, et al. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: Important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 2002; 22: 1838-1844.
16. Marklund S. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 1982; 79: 7634-7638.
17. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: Role of heparin binding domain. Circ Res 2003; 92: 461-468.
18. Watanabe Y, Chu Y, Andresen JA, Nakane H, Faraci FM, Heistad DD. Gene transfer of extracellular SOD reduces vasospasm following subarachnoid hemorrhage. Stroke 2003; 34: 434-440.
19. Folz RJ, Peno GL, Crapo JD. Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum Mol Genet 1994; 3: 2251-2254.
20. Adachi T, Yamada H, Yamada Y, Morihara N, Yamazaki N, Murakami T, et al. Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem J 1996; 313: 235-239.
21. Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwell LR, et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction in isolated murine hearts. Circulation 1994; 89: 1982-1991.
22. Li Q, Bolli R, Qui Y, Tang XL, Guo Y, French BA. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 2001; 103: 1893-1898.
23. Arimura K, Egashira K, Nakamura R, Ide T, Tsutsui H, Shimokawa H, et al. Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure. Am J Physiol Heart 2001; 280: H68-H75.
24. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine oxidase and extracellular superoxide dismutase. Circulation 2002; 106: 3073-3078.
25. Hansson G. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 1876-1890.
26. Gunnett CA, Lund DD, Chu Y, Brooks RM, Faraci FM, Heistad DD. NO-dependent vasorelaxation is impaired after gene transfer of inducible NO synthase. Arterioscler Thromb Vasc Biol 2001; 21: 1281-1287.
27. Gunnett CA, Lund DD, Howard MA, Chu Y, Faraci FM, Heistad DD. Gene transfer of inducible NO-synthase impairs relaxation in human and rabbit cerebral arteries. Stroke 2002; 33: 2292-2296.
28. Gunnett CA, Heistad DD, Berg DJ, Faraci FM. IL-10 deficiency increases superoxide and endothelium dysfunction during inflammation. Am J Physiol Heart 2000; 279: H1555-H1562.
29. Gunnett CA, Heistad DD, Faraci FM. Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: Role of superoxide. Diabetes 2002; 51: 1931-1937.
30. Pinderski Oslund LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo, Arterioscler Thromb Vasc Biol 1999; 19: 2847-2853.
31. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003; 107: 2109-2114.
32. Armstrong ML, Warner E, Connor W. Regression of coronary atheromatosis in rhesus monkeys. Circ Res 1970; 27: 59-67.
33. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987; 80: 1808-1811.
34. Hathaway C, Heistad DD, Piegors DJ, Miller FM. Regression of atherosclerosis in monkeys reduces vascular superoxide levels. Circ Res 2002; 90: 277-283.
35. Padgett RC, Heistad DD, Mügge A, Armstrong ML, Piegors DJ, Lopez JAG. Vascular responses to activated leukocytes after regression of atherosclerosis. Circ Res 1992; 70: 423-429.
36. Lentz SR, Fernandez JA, Griffin JH, Piegors DJ, Erger RA, Malinow MR, et al. Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with acquired defects in the Protein C system. Arterioscler Thromb Vasc Biol 1999; 19: 1744-1750.
37. Lentz SR, Miller FM Jr, Piegors DJ, Erger RA, Fern·ndez JA, Griffin JH, et al. Anticoagulant responses to thrombin are enhanced during regression of atherosclerosis in monkeys. Circulation 2002; 106: 842-846.
38. Brown BG, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan CK, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-1298.